Koyfin Home > Directory > Health Care > Antares Pharma > Net Income

Antares Pharma Net Income Chart (ATRS)

Antares Pharma annual/quarterly Net Income from 2000 to 2018. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Antares Pharma Net Income for the quarter ending December 12, 2018 was $6m a 200.96% increase of 12m year over year
  • Antares Pharma Net Income for the last 12 months ending December 12, 2018 was $-7m a -179.36% increase of 12m year over year
  • Antares Pharma Annual Net Income for 2018 was $-7m a -156.99% increase of 10m from 2017
  • Antares Pharma Annual Net Income for 2017 was $-17m a -45.37% increase of 8m from 2016
  • Antares Pharma Annual Net Income for 2016 was $-24m a 15.12% decrease of -4m from 2015
Other Income Statement Metrics:
  • Antares Pharma EBITDA for the quarter ending December 12, 2018 was $-5m a 1.88% decrease of 0m year over year
  • Antares Pharma Total Revenue for the quarter ending December 12, 2018 was $19m a 32.51% increase of 6m year over year
View Chart On Koyfin

Quarterly ATRS Net Income Data

12/2018$6m
09/2018$-2m
06/2018$-5m
03/2018$-6m
12/2017$-4m
09/2017$-5m
06/2017$-3m
03/2017$-5m
12/2016$-5m
09/2016$-6m

Annual ATRS Net Income Data

2018$-7m
2017$-17m
2016$-24m
2015$-21m
2014$-35m
2013$-21m
2012$-11m
2011$-4m
2010$-6m
2009$-10m